Paul Statkevich

6.9k citations
92 papers · 4.9k · 1 hit paper · h-index 35

Impact in

  • Genetics top 1%
    • Glioma Diagnosis and Treatment
  • Oncology top 1%
    • CAR-T cell therapy research
    • Cutaneous Melanoma Detection and Management
    • Cancer-related Molecular Pathways
    • Cancer Immunotherapy and Biomarkers

Papers in

Paul Statkevich

91 papers receiving 4.7k citations

Paul Statkevich's Hit Papers

Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma 2000 · 938 citations
9380+8+17Years since publication250500750

Peers

Paul Statkevich
Comparison fields: 5 of 120
  • Genetics 831
  • Oncology 1.7k
  • Cancer Research 486
  • Pulmonary and Respiratory Medicine 732
  • Pharmacology 210
Replace Jean L. Grem with:
Jean L. Grem United States
Jan H. Beumer United States
Neeltje Steeghs Netherlands
Markus Joerger Switzerland
Louise B. Grochow United States
Raymond J. Hohl United States
René Bruno France
Guido Bocci Italy
Suzanne F. Jones United States
Scott M. Wilhelm United States
Paul Statkevich relative to Jean L. Grem United States Jean L. Grem's profile →
Citations per field
00.5×2.5×
Jean L. Grem · 1×
Citations per year

Countries citing papers authored by Paul Statkevich

Since Specialization
Citations

This map shows the geographic impact of Paul Statkevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Statkevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Statkevich more than expected).

Fields of papers citing papers by Paul Statkevich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Statkevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Statkevich. The network helps show where Paul Statkevich may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Statkevich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Statkevich Line = papers co-authored together Paul Statkevich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
Hit paper breakdown →
2000938
2 2005368
3 2003285
4
Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
1999194
5 1999179
6 2002133
7 2013124
8 2002119
9 1999118
10 2013105
11 2001100
12 200594
13 200194
14 200291
15 200290
16 201382
17 200582
18 200170
19
A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
199963
20 201659

About Paul Statkevich

Paul Statkevich is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Surgery, having authored 92 papers that have together received 4.9k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (15 papers), Lipoproteins and Cardiovascular Health (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Glioma Diagnosis and Treatment (8 papers), CAR-T cell therapy research (7 papers), Cancer Treatment and Pharmacology (6 papers) and Synthesis of β-Lactam Compounds (6 papers). The work is most often cited by research in Genetics (831 citations), Oncology (1.7k citations), Cancer Research (486 citations), Pulmonary and Respiratory Medicine (732 citations) and Pharmacology (210 citations). Paul Statkevich has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Teddy Kosoglou, David L. Cutler, Kevin B. Alton, Yali Zhu, Amy O. Johnson‐Levonas, Arthur Bergman, Larisa Reyderman, John F. Paolini, Uwe Fraass and Vijay Batra. Their work appears in journals such as The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, Current Medical Research and Opinion and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact